Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07695727

Targeting GLUT1 to Control Autoimmunity in Type 1 Diabetes

Sponsor: IRCCS San Raffaele

View on ClinicalTrials.gov

Summary

Type 1 Diabetes is an autoimmune disease in which immune cells contribute to the destruction of insulin-producing pancreatic beta cells. This study investigates whether targeting glucose transporter 1 (GLUT1), a transporter involved in immune cell metabolism, may help modulate autoimmune responses associated with Type 1 Diabetes. The study uses previously collected and biobanked peripheral blood mononuclear cells (PBMCs) from individuals with Type 1 Diabetes. No additional visits, blood draws, or study-specific procedures will be performed on human participants.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

84

Start Date

2026-09

Completion Date

2029-09

Last Updated

2026-07-14

Healthy Volunteers

No

Locations (1)

IRCCS San Raffaele Scientific Institute

Milan, Italy